Infection-dependent antibiotic response phenotypes emerge during chronic airway adaptation of Pseudomonas aeruginosa
Pablo LabordaiD, Esmeralda Cebrián-SastreiD, Ruggero La RosaiD, Søren MoliniD, Helle Krogh JohanseniD
Abstract
Objectives Chronic Pseudomonas aeruginosa airway infections can persist for years despite intensive antibiotic therapy guided by standard antimicrobial susceptibility testing. While this technique captures the emergence of resistance, it does not reproduce many features of the infection environment, where adaptation acquired during chronic infection may alter bacterial responses to antibiotics in ways that are not fully reflected by conventional susceptibility testing. Here we investigated antibiotic responses of longitudinal clinical isolates under standard laboratory conditions and in an airway epithelial infection model. Methods Six longitudinal pairs of P. aeruginosa isolates from people with cystic fibrosis were analysed. Changes in bacterial growth following exposure to tobramycin, ceftazidime and ciprofloxacin were quantified under standard laboratory conditions and compared with changes in bacterial burden after treatment measured in differentiated airway epithelial cultures maintained under air-liquid interface (ALI) conditions that reproduce key features of the airway infection environment. Representative phenotypes were visualized by confocal microscopy and interpreted in the context of available whole-genome sequencing data. Results Major resistance phenotypes identified by conventional susceptibility testing were largely reproduced in the ALI model. However, concordance between phenotypes observed under standard laboratory and ALI conditions differed between antibiotics. Several isolates classified as susceptible according to conventional susceptibility testing displayed substantial survival in the ALI model, and these discordant phenotypes were observed predominantly among those isolates recovered after prolonged airway persistence. Genomic analyses identified mutations associated with both classical resistance mechanisms and chronic adaptation. Conclusions Phenotypes observed under conventional laboratory conditions do not uniformly predict those observed in the ALI airway conditions. Discordant phenotypes were most apparent among chronically adapted isolates and varied between antibiotics, suggesting that adaptation acquired during chronic infection can alter antibiotic responses in ways that are not fully reflected by conventional susceptibility testing.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- How long does it take to cue a Pseudomonas aeruginosa chronic infection phenotype in the lab? Insights from transcriptome analysis in a cystic fibrosis lung model.
N. E. Harrington, F. Allen, … F. Harrison·bioRxiv·Jun 30, 2022
- Long-term evolution of antibiotic persistence in P. aeruginosa lung infections
M. Ghoul, S. B. Andersen, … A. S. Griffin·bioRxiv·Oct 14, 2021
- Pseudomonas aeruginosa evolves to an infection state of reduced virulence and enhanced survival during antibiotic selection in an airway tissue model
Albano H. Tenaglia, Claudia Antonella Colque, … Andrea M. Smania·bioRxiv·Oct 22, 2026
- Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection
Matthew A. Greenwald, Suzanne L. Meinig, … Matthew C. Wolfgang·mBioPeer-reviewed·Apr 23, 2024
- Long-term adaptation to hypoxia provides insight into mechanisms facilitating the switch of Pseudomonas aeruginosa to chronic lung infections
Joanna Drabinska, Lucia O’Connor, … Siobhán McClean·bioRxiv·Dec 26, 2024
- In vitro persistence level reflects in vivo antibiotic survival of natural Pseudomonas aeruginosa isolates in a murine lung infection model
L. Verstraete, J. Aizawa, … P. Cos·bioRxiv·Oct 21, 2022